Skip to main content

Geveden Rex D's Form 4 filing

BWX Technologies, Inc.BWXT · filed Feb 28, 2025

Accession no.
0001628280-25-009206
Filed
Feb 28, 2025
Trade date
Feb 26-27, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $4.90M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Geveden Rex DCIK 0001408482Director, Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 26, 2025Common StockSSaleDisposed−29,882$107.13F1−$3,201,258.66233,961Direct
Feb 26, 2025Common StockSSaleDisposed−15,743$107.91F2−$1,698,827.13218,218Direct
Feb 27, 2025Common StockMOption exerciseAcquired+4,538$0.00$0222,756Direct
Feb 27, 2025Common StockFTax withholdingDisposed−1,919$106.64−$204,642.16220,837Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 26, 2025Common StockAGrant or awardAcquired+10,314$0.00$010,314Direct
Feb 26, 2025Common StockAGrant or awardAcquired+39,483$0.00$039,483Direct
Feb 27, 2025Common StockMOption exerciseDisposed−4,538$0.00$04,259Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price in Column 4 is a weighted average price. The shares were sold at prices ranging from $106.630 to $107.620 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Referenced by the price of 1 transaction in Table I.

F2

The price in Column 4 is a weighted average price. The shares sold at prices ranging from $107.630 to $108.325 inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)